Sumatriptan and others are contraindicated in patients taking monoamine oxidase (MAO) inhibitors or within 2 weeks of stopping one. They are deemed pregnancy category C (risk cannot be ruled out).
The supplementation of a whey-derived peptide has been shown to lower self-perceived levels of stress among middle-aged ...